✦ LIBER ✦

Patient-Specific Vaccines Derived from Autologous Tumor Cell Lines as Active Specific Immunotherapy: Results of Exploratory Phase I/II Trials in Patients with Metastatic Melanoma

✍ Scribed by Dillman, Robert O.; DePriest, Carol; DeLeon, Cristina; Barth, Neil M.; Schwartzberg, Lee S.; Beutel, Linda D.; Schiltz, Patric M.; Nayak, Shankar K.

Book ID: 121395957
Publisher: Mary Ann Liebert
Year: 2007
Tongue: English
Weight: 319 KB
Volume: 22
Category: Article
ISSN: 1084-9785
DOI: 10.1089/cbr.2007.345

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II Trial of Dendritic Cells Loaded

Phase II Trial of Dendritic Cells Loaded with Antigens from Self-Renewing, Proliferating Autologous Tumor Cells as Patient-Specific Antitumor Vaccines in Patients with Metastatic Melanoma: Final Report

✍ Dillman, Robert O.; Selvan, Senthamil R.; Schiltz, Patric M.; McClay, Edward F.; 📂 Article 📅 2009 🏛 Mary Ann Liebert 🌐 English ⚖ 216 KB

Vaccination with autologous dendritic ce

Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial

✍ Trepiakas, Redas; Berntsen, Annika; Hadrup, Sine Reker; Bjørn, Jon; Geertsen, Po 📂 Article 📅 2010 🏛 Informa plc 🌐 English ⚖ 317 KB

2110 POSTER Active specific immunotherap

2110 POSTER Active specific immunotherapy with NGcGM3/ VSSP/ Montanide ISA-51 (CIMAVaxG) vaccine in the treatment of patients with metastatic breast cancer: Results of a randomized phase II clinical trial

✍ A. Macias; A. Torres; A. Montenegro; P. Marinello; R. Rodriguez; V. Mulens; A. C 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 57 KB